Matinas BioPharma 10K 2021 Annual report | MTNB Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AAV, activist, ALC, APLI, APLIF, array, broadened, campaign, Carolina, chain, Chapel, CI, cold, congestion, Corzo, drawback, driven, EFA, electrolyte, element, Eli, engineer, esophageal, extracellular, fluorescent, footprint, gastric, gateway, gathered, geopolitical, GoodCap, GSK, Hill, Hoffman, Hoover, ID, ImmuneID, immunological, immunology, Inline, inoculum, intolerant, intranasally, intrathecal, Kathryn, Kingdom, legacy, Lilly, LNP, Lu, LYPIDISO, macro, macroeconomic, masked, mediated, Millendo, murine, Myeloma, NeuBase, neutral, North, oropharyngeal, OTCQX, page, Perlin, Peter, problematic, receptor, redefining, regenerative, reinforced, RPh, run, Russian, serotype, Sloan, SoC, sterile, sterility, sterilization, Sunovion, Syndax, TAK, Takeda, Tempest, tissue, TSE, Ukraine, UNC, unregistered, unwind, vector, virtue, virulent, Williamson, Zarif

Removed: AbbVie, abdominal, abeyance, abnormal, abroad, absolute, accreted, accrue, AI, aimed, allocable, altering, Amarin, announcement, apo, approaching, ASO, Astra, ASU, atherosclerotic, AUC, baseline, basket, BCF, bio, Boardroom, Boron, bridging, build, CAD, calculating, call, caloric, capitalization, capsule, Cardinal, CIII, clarified, Cmax, COD, comorbid, compatibility, competitor, conception, concomitant, conjunction, consummated, contingency, controlled, coronary, corrected, crossover, CV, daily, declaration, declining, define, demanding, DHA, diabetic, diagnose, Dickinson, diet, dietary, differentiation, diligence, disability, docosapentanoic, DOJ, dramatic, dyslipidemia, dyslipidemic, Easement, eicosapentaenoate, eicosapentanoic, elevated, emergent, encountered, ENDP, enhanced, Epadel, epanova, epidemiological, equally, ester, ethyl, exact, examine, expedient, expensing, explored, failed, Fairleigh, fasting, fat, fed, fenofibrate, fibrate, fish, flucytosine, focusing, Fordham, Forty, freestanding, gelatin, gemfibrozil, Glaxo, highlight, Hoffmann, HTG, hypertriglyceridemia, icosapent, immunosuppressed, implicitly, infarction, introduction, ischemic, issuing, Japanese, Justice, launched, LDL, lifestyle, Likewise, linked, lipoprotein, liquidity, Lopid, Lovaza, LP, LPAD, Master, meal, median, men, mg, migration, mild, mitigate, mixed, mixture, Mochida, modest, monotherapy, myocardial, nausea, NCEP, nephrotic, neurological, niacin, Niaspan, nm, noted, obesity, Observational, Omacor, Omthera, operated, origination, Patrick, PD, pharmacodynamic, PharMerica, phenomena, pill, placebo, practical, predictive, predictor, pregnancy, premarket, presently, promptly, provisional, purified, push, reader, Ready, real, reclassified, recording, recurrent, recurring, refine, reforming, regulating, reliable, remained, remediate, remediation, replaced, repurposed, resale, rest, retrospective, robust, Seacor, secondary, sedentary, serum, SHTG, simultaneously, smaller, soft, sophisticated, SOX, statin, statistical, steadily, streamlined, stroke, strongly, sudden, suffering, suggest, syndrome, synergistic, taxation, taxing, territorial, TG, TGs, ThinkEquity, Tmax, top, Tricor, Trilipix, trustee, twenty, unconverted, understand, Undetected, undisclosed, unpaid, upper, Villanova, VLDL, washout, WellFit, western, Zeneca

Name		State of Incorporation

Matinas BioPharma, Inc.		Delaware

Matinas BioPharma Nanotechnologies, Inc.		Delaware

Matinas BioPharma (MTNB) 10-K2021 FY Annual report

Content analysis